Anavex Life Sciences (AVXL)
(Delayed Data from NSDQ)
$10.97 USD
+0.08 (0.73%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $10.97 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Anavex Life Sciences Corp. has a market cap of $930.19M, which represents its share price of $10.89 multiplied by its outstanding shares number of 85.42M. As a small-cap company, AVXL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AVXL 10.97 +0.08(0.73%)
Will AVXL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVXL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVXL
Are You Looking for a Top Momentum Pick? Why Anavex Life Sciences (AVXL) is a Great Choice
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
AVXL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus
Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why
Best Momentum Stocks to Buy for January 21st
Other News for AVXL
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August ...
Anavex Life Sciences (AVXL) Maintains 'Buy' Rating with $46 Target | AVXL Stock News
Anavex (AVXL) Reveals Promising Data for Alzheimer's Treatment
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral ...
Anavex announces precision medicine results of oral blarcamesine treatment